{"id":"W2526572293","doi":"10.1007/s40487-016-0030-2","title":"Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma","year":2016,"lang":"en","type":"article","venue":"Oncology and Therapy","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Dabrafenib; Trametinib; Vemurafenib; Ipilimumab; Medicine; Dacarbazine; Internal medicine; Oncology; Hazard ratio; Progression-free survival; Melanoma; Confidence interval; Metastatic melanoma; Cancer research; Chemotherapy; Cancer; Biology; Immunotherapy; MAPK/ERK pathway","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002981981,0.0001442833,0.0007274847,0.00007142033,0.00003454596,0.000002947277,0.00007119347,0.0001083764,0.0000564119],"category_scores_gemma":[0.00002572824,0.00008345229,0.0001810752,0.0001066544,0.0001384348,0.000004659008,0.00003324579,0.00002180991,2.304915e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009770393,"about_ca_system_score_gemma":0.00004918514,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008186136,"about_ca_topic_score_gemma":0.0009295553,"domain_scores_codex":[0.9989671,0.0002684458,0.0002818507,0.0002543752,0.00008095677,0.0001473402],"domain_scores_gemma":[0.9992242,0.0002720331,0.0001828963,0.0002179053,0.00005660464,0.00004631487],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01020266,0.00468784,0.2500649,0.00008548587,0.2427293,0.0002377746,0.002187121,0.0004680764,0.2292728,0.01816646,0.0002177166,0.2416799],"study_design_scores_gemma":[0.04930663,0.06746943,0.490435,0.00005679659,0.07283852,0.0000953394,0.0004762605,0.0003954804,0.275414,0.02180973,0.0200819,0.001620925],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895732,0.008581823,0.000539874,0.0004794262,0.0000626553,0.0002484467,0.0001274111,0.000002731821,0.0003843625],"genre_scores_gemma":[0.9954143,0.003603513,0.0006299228,0.00004411142,0.00003795513,0.00004792492,0.00006750094,0.000008196519,0.000146587],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2403702,"threshold_uncertainty_score":0.3403086,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05188755218340509,"score_gpt":0.320069913384466,"score_spread":0.2681823612010609,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}